文献速递其他结缔组织病

B细胞清除通过抑制促纤维化巨噬细胞分化抑制系统性硬化症小鼠模型纤维化

B Cell Depletion Inhibits Fibrosis via Suppression of Profibrotic Macrophage Differentiation in a Mouse Model of Systemic Sclerosis.
PubMed 文献 · Arthritis Rheumatol · 2021-09-28

该研究在博来霉素诱导的系统性硬化症(SSc)小鼠模型中探讨B细胞清除对纤维化的作用及机制。结果显示B细胞清除可抑制皮肤和肺纤维化,其机制与抑制促纤维化巨噬细胞分化有关;SSc患者中B细胞诱导促纤维化巨噬细胞的程度与纤维化严重度相关。

要点

  • B细胞清除可抑制BLM-SSc小鼠的皮肤和肺纤维化。
  • B细胞清除对纤维化的抑制作用与促纤维化巨噬细胞减少相关。
  • SSc患者中B细胞诱导促纤维化巨噬细胞与纤维化严重度相关。

核心结论

  • B细胞清除通过抑制促纤维化巨噬细胞分化抑制BLM-SSc小鼠的组织纤维化,为SSc的B细胞清除治疗提供新依据。

研究设计与样本

  • 博来霉素诱导的SSc(BLM-SSc)小鼠接受抗CD20抗体治疗,并进行组织病理学评估。
  • 体外共培养小鼠及SSc患者的B细胞与T细胞、巨噬细胞或单核细胞,用流式细胞术评估分化影响。
  • 比较BLM处理前(pre-depletion)与BLM处理后(post-depletion)进行B细胞清除对纤维化的影响。

主要发现

  • B细胞清除抑制BLM-SSc小鼠的纤维化。
  • BLM-SSc小鼠的B细胞在共培养中增加产生促炎细胞因子的T细胞。
  • pre-depletion对纤维化的抑制强于post-depletion(P < 0.01)。
  • post-depletion组促炎T细胞频率低于pre-depletion组,提示B细胞清除对纤维化的作用不能仅由T细胞分化解释。
  • pre-depletion组促纤维化巨噬细胞较post-depletion组显著减少(P < 0.05);BLM-SSc小鼠B细胞在共培养中增加促纤维化巨噬细胞分化(P < 0.05);SSc患者B细胞诱导促纤维化巨噬细胞的程度与纤维化严重度相关(P < 0.0005)。

临床怎么用

  • 在SSc中,B细胞清除的潜在抗纤维化作用可能与抑制促纤维化巨噬细胞分化有关。
  • B细胞诱导促纤维化巨噬细胞的能力或可反映SSc患者纤维化严重程度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We undertook this study to investigate the effect of B cell depletion on fibrosis in systemic sclerosis (SSc) and its mechanism of action. METHODS: Mice with bleomycin-induced SSc (BLM-SSc) were treated with anti-CD20 antibody, and skin and lung fibrosis were histopathologically evaluated. T cells and macrophages were cocultured with B cells, and the effect of B cells on their differentiation was assessed by flow cytometry. We also cocultured B cells and monocytes from SSc patients and analyzed the correlation between fibrosis and profibrotic macrophage induction by B cells. RESULTS: B cell depletion inhibited fibrosis in mice with BLM-SSc. B cells from mice with BLM-SSc increased proinflammatory cytokine-producing T cells in coculture. In mice with BLM-SSc, B cell depletion before BLM treatment (pre-depletion) inhibited fibrosis more strongly than B cell depletion after BLM treatment (post-depletion) (P < 0.01). However, the frequencies of proinflammatory T cells were lower in the post-depletion group than in the pre-depletion group. This discrepancy suggests that the effect of B cell depletion on fibrosis cannot be explained by its effect on T cell differentiation. On the other hand, profibrotic macrophages were markedly decreased in the pre-depletion group compared to the post-depletion group (P < 0.05). Furthermore, B cells from mice with BLM-SSc increased profibrotic macrophage differentiation in coculture (P < 0.05). In SSc patients, the extent of profibrotic macrophage induction by B cells correlated with the severity of fibrosis (P < 0.0005). CONCLUSION: These findings suggest that B cell depletion inhibits tissue fibrosis via suppression of profibrotic macrophage differentiation in mice with BLM-SSc, providing a new rationale for B cell depletion therapy in SSc.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Numajiri H, Kuzumi A, Fukasawa T, et al. B Cell Depletion Inhibits Fibrosis via Suppression of Profibrotic Macrophage Differentiation in a Mouse Model of Systemic Sclerosis. Arthritis Rheumatol. 2021. PMID: 33955200. doi:10.1002/art.41798

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。